Efficacy of nebulised versus intravenous tranexamic acid in management of non-massive haemoptysis: A randomised controlled trial

Introduction: Intravenous (IV) tranexamic acid (TXA), an antifibrinolytic agent, is routinely used in the treatment of non-massive haemoptysis. Topical TXA has shown haemostatic efficacy in surgical settings and epistaxis. Limited case reports have documented successful management of pulmonary bleed...

Description complète

Détails bibliographiques

Auteurs principaux:	Vasudha Dinesh, T.P Elamurugan, Arun A. Mohanan, G. Vishnukanth
Format:	Artigo
Langue:	Inglês
Publié:	Wolters Kluwer Medknow Publications 2026-01-01
Collection:	Lung India
Sujets:	intravenous tranexamic acid nebulised tranexamic acid non-massive haemoptysis
Accès en ligne:	https://journals.lww.com/10.4103/lungindia.lungindia_264_25
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!